TAK Annual FCF
$1.63 B
-$910.80 M-35.81%
31 March 2024
Summary:
As of January 23, 2025, TAK annual free cash flow is $1.63 billion, with the most recent change of -$910.80 million (-35.81%) on March 31, 2024. During the last 3 years, it has fallen by -$5.67 billion (-77.65%). TAK annual FCF is now -80.44% below its all-time high of $8.35 billion, reached on March 31, 2022.TAK Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TAK Quarterly FCF
$1.28 B
+$1.07 B+513.59%
01 September 2024
Summary:
As of January 23, 2025, TAK quarterly free cash flow is $1.28 billion, with the most recent change of +$1.07 billion (+513.59%) on September 1, 2024. Over the past year, it has increased by +$1.07 billion (+513.59%). TAK quarterly FCF is now -56.66% below its all-time high of $2.95 billion, reached on March 31, 2022.TAK Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TAK TTM FCF
$3.45 B
+$322.87 M+10.32%
01 September 2024
Summary:
As of January 23, 2025, TAK TTM free cash flow is $3.45 billion, with the most recent change of +$322.87 million (+10.32%) on September 1, 2024. Over the past year, it has increased by +$322.87 million (+10.32%). TAK TTM FCF is now -58.63% below its all-time high of $8.35 billion, reached on March 31, 2022.TAK TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TAK Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.8% | +513.6% | +10.3% |
| 3 y3 years | -77.7% | +233.4% | +35.8% |
| 5 y5 years | -6.9% | -51.9% | -52.7% |
TAK Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -80.4% | at low | -56.7% | +199.3% | -58.6% | +523.8% |
| 5 y | 5-year | -80.4% | at low | -56.7% | +199.3% | -58.6% | +523.8% |
| alltime | all time | -80.4% | +430.0% | -56.7% | +191.5% | -58.6% | +427.4% |
Takeda Pharmaceutical Company Limited Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.28 B(+513.6%) | $3.45 B(+10.3%) |
| June 2024 | - | $208.52 M(-86.0%) | $3.13 B(+91.7%) |
| Mar 2024 | $1.63 B(-35.8%) | $1.49 B(+212.2%) | $1.63 B(-300.4%) |
| Dec 2023 | - | $476.74 M(-50.2%) | -$814.80 M(-180.8%) |
| Sept 2023 | - | $956.59 M(-174.2%) | $1.01 B(-26.1%) |
| June 2023 | - | -$1.29 B(+34.3%) | $1.36 B(-46.4%) |
| Mar 2023 | $2.54 B(-69.5%) | -$959.41 M(-141.7%) | $2.54 B(-60.6%) |
| Dec 2022 | - | $2.30 B(+75.2%) | $6.45 B(-3.6%) |
| Sept 2022 | - | $1.31 B(-1303.2%) | $6.70 B(-5.7%) |
| June 2022 | - | -$109.09 M(-103.7%) | $7.10 B(-14.9%) |
| Mar 2022 | $8.35 B(+14.3%) | $2.95 B(+16.2%) | $8.35 B(+3.7%) |
| Dec 2021 | - | $2.54 B(+48.0%) | $8.05 B(+11.4%) |
| Sept 2021 | - | $1.72 B(+50.9%) | $7.23 B(-3.2%) |
| June 2021 | - | $1.14 B(-57.2%) | $7.46 B(+2.2%) |
| Mar 2021 | $7.31 B(+75.7%) | $2.66 B(+54.8%) | $7.31 B(+26.5%) |
| Dec 2020 | - | $1.72 B(-12.1%) | $5.78 B(+25.0%) |
| Sept 2020 | - | $1.95 B(+99.3%) | $4.62 B(+4.4%) |
| June 2020 | - | $979.32 M(-13.3%) | $4.43 B(+6.5%) |
| Mar 2020 | $4.16 B(+137.2%) | $1.13 B(+100.6%) | $4.16 B(+12.2%) |
| Dec 2019 | - | $562.75 M(-68.0%) | $3.71 B(+0.5%) |
| Sept 2019 | - | $1.76 B(+148.5%) | $3.69 B(+52.8%) |
| June 2019 | - | $707.93 M(+4.7%) | $2.41 B(+37.7%) |
| Mar 2019 | $1.75 B(-22.2%) | $676.10 M(+24.3%) | $1.75 B(-12.8%) |
| Dec 2018 | - | $544.05 M(+12.1%) | $2.01 B(-1.0%) |
| Sept 2018 | - | $485.30 M(+916.4%) | $2.03 B(+8.1%) |
| June 2018 | - | $47.75 M(-94.9%) | $1.88 B(-16.6%) |
| Mar 2018 | $2.25 B(+63.1%) | $933.11 M(+65.5%) | $2.25 B(+6.3%) |
| Dec 2017 | - | $563.90 M(+69.2%) | $2.12 B(+50.5%) |
| Sept 2017 | - | $333.21 M(-21.1%) | $1.41 B(-4.0%) |
| June 2017 | - | $422.46 M(-47.1%) | $1.47 B(+6.2%) |
| Mar 2017 | $1.38 B | $798.90 M(-644.4%) | $1.38 B(-269.0%) |
| Dec 2016 | - | -$146.74 M(-137.4%) | -$816.88 M(+268.8%) |
| Sept 2016 | - | $392.19 M(+16.5%) | -$221.51 M(+20.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | $336.58 M(-124.1%) | -$183.21 M(-63.0%) |
| Mar 2016 | -$494.72 M(-173.3%) | -$1.40 B(-411.8%) | -$494.72 M(-148.4%) |
| Dec 2015 | - | $448.64 M(+4.2%) | $1.02 B(+15.5%) |
| Sept 2015 | - | $430.48 M(+1617.2%) | $884.98 M(-9.1%) |
| June 2015 | - | $25.07 M(-78.7%) | $973.73 M(+44.3%) |
| Mar 2015 | $674.86 M(-3.7%) | $117.69 M(-62.2%) | $674.86 M(-51.3%) |
| Dec 2014 | - | $311.74 M(-40.0%) | $1.39 B(+2.1%) |
| Sept 2014 | - | $519.23 M(-289.6%) | $1.36 B(-8.4%) |
| June 2014 | - | -$273.80 M(-133.0%) | $1.48 B(+111.4%) |
| Mar 2014 | $700.90 M(-73.7%) | $829.11 M(+193.2%) | $700.90 M(-646.7%) |
| Dec 2013 | - | $282.76 M(-56.1%) | -$128.20 M(-68.8%) |
| Sept 2013 | - | $643.77 M(-161.0%) | -$410.96 M(-61.0%) |
| June 2013 | - | -$1.05 B(-189.2%) | -$1.05 B(-144.8%) |
| Mar 2013 | $2.67 B(-20.8%) | - | - |
| Mar 2012 | $3.36 B(+42.9%) | - | - |
| Mar 2011 | $2.36 B(-25.7%) | $1.18 B(+176.1%) | $2.36 B(+20.6%) |
| Dec 2010 | - | $428.34 M(-49.4%) | $1.95 B(-10.2%) |
| Sept 2010 | - | $845.79 M(-930.1%) | $2.18 B(-8.3%) |
| June 2010 | - | -$101.89 M(-113.0%) | $2.37 B(-25.2%) |
| Mar 2010 | $3.17 B(+9.9%) | $781.13 M(+20.2%) | $3.17 B(+32.7%) |
| Dec 2009 | - | $650.04 M(-37.7%) | $2.39 B(+37.4%) |
| Sept 2009 | - | $1.04 B(+49.7%) | $1.74 B(+149.7%) |
| June 2009 | - | $696.73 M | $696.73 M |
| Mar 2009 | $2.88 B(+26.5%) | - | - |
| Mar 2008 | $2.28 B(+48.0%) | - | - |
| Mar 2007 | $1.54 B(-49.0%) | - | - |
| Mar 2006 | $3.02 B(+34.0%) | - | - |
| Mar 2005 | $2.25 B(-1.1%) | - | - |
| Mar 2004 | $2.28 B(+20.7%) | - | - |
| Mar 2003 | $1.89 B(+16.2%) | - | - |
| Mar 2002 | $1.63 B(-3.4%) | - | - |
| Mar 2001 | $1.68 B(+51.1%) | - | - |
| Mar 2000 | $1.11 B | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual free cash flow?
- What is the all time high annual FCF for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual FCF year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly free cash flow?
- What is the all time high quarterly FCF for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly FCF year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM free cash flow?
- What is the all time high TTM FCF for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM FCF year-on-year change?
What is Takeda Pharmaceutical Company Limited annual free cash flow?
The current annual FCF of TAK is $1.63 B
What is the all time high annual FCF for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual free cash flow is $8.35 B
What is Takeda Pharmaceutical Company Limited annual FCF year-on-year change?
Over the past year, TAK annual free cash flow has changed by -$910.80 M (-35.81%)
What is Takeda Pharmaceutical Company Limited quarterly free cash flow?
The current quarterly FCF of TAK is $1.28 B
What is the all time high quarterly FCF for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly free cash flow is $2.95 B
What is Takeda Pharmaceutical Company Limited quarterly FCF year-on-year change?
Over the past year, TAK quarterly free cash flow has changed by +$1.07 B (+513.59%)
What is Takeda Pharmaceutical Company Limited TTM free cash flow?
The current TTM FCF of TAK is $3.45 B
What is the all time high TTM FCF for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM free cash flow is $8.35 B
What is Takeda Pharmaceutical Company Limited TTM FCF year-on-year change?
Over the past year, TAK TTM free cash flow has changed by +$322.87 M (+10.32%)